Debates & Insight Sponsored The evolution of pharma social media intelligence Is your company a fully mature user of intelligence from social media, or is it still not tapping into insights?
Partner Content Partner Content Making the most of your remaining communications budget pharmaphorum connect's Mark Walmsley describes seven projects to maximise remaining communications budgets.
Debates & Insight Sponsored Available on demand: Establishing a Solid Foundation for Dig... Available on demand: Join us for a one-hour live webinar entitled Establishing a Solid Foundation for Digital Transformation.
Debates & Insight Sponsored Available on demand: Social medical: The social media buzz a... Join us for a one-hour live webinar discussing the social media buzz around this year’s ASCO Annual Meeting.
Articles Digital health round-up: smart inhalers, 3D printing and mor... A round-up of this week's top digital healthcare news. Marco Ricci reports.
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.